Company Filing History:
Years Active: 2016
Title: Innovations in Clostridium Infection Treatment by John Hudson Moore, II
Introduction
John Hudson Moore, II is an accomplished inventor based in Richmond, VA. He has made significant contributions to the field of medical treatment, particularly in addressing Clostridium difficile infection (CDI). His innovative approach aims to improve patient outcomes and reduce the recurrence of this common antibiotic-associated condition.
Latest Patents
John Hudson Moore, II holds a patent for "Compositions and methods for treating clostridium infection and preventing recurrence of infection." This patent addresses the challenges associated with CDI, which is a leading cause of antibiotic-associated diarrhea. Traditional antibiotic therapy often leads to relapses, necessitating prolonged treatment courses. Moore's patent proposes that a lower dose or shorter course of antimicrobial treatment can effectively manage the disease while promoting a robust immunologic response and preserving normal flora, thereby reducing the risk of relapses.
Career Highlights
Moore is affiliated with the University of Virginia Patent Foundation, where he continues to advance his research and innovations. His work is pivotal in the ongoing efforts to enhance treatment protocols for CDI, which affects numerous patients worldwide.
Collaborations
Moore has collaborated with notable colleagues, including Richard Littleton Guerrant and Cirle Alcantara Warren. These partnerships have contributed to the development and refinement of his innovative treatment methods.
Conclusion
John Hudson Moore, II's contributions to the treatment of Clostridium difficile infection represent a significant advancement in medical science. His innovative patent offers a promising alternative to traditional antibiotic therapies, potentially improving patient care and outcomes.